Skip to content
Recall Observatory FDA recall evidence

Drug product

Gemcitabine, Sterile Intravesical Solution, Preservative Free, 1g/50mL (20 mg/mL), 50 mL per syringe, Single Dose Syringe for Intravesical Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1566-50

D-0403-2022

December 06, 2021

Class II

Product summary

Firm
Edge Pharma, LLC
Event
Event 89172
Status
Terminated
Classification
Class II
Quantity
627 syringes
Official record key
drug-enforcement:D-0403-2022

Official wording

Reason: Lack of Assurance of Sterility

Code information: 08-2021-18@1 12/14/2021, 08-2021-27@1 12/09/2021, 09-2021-01@4 12/14/2021, 09-2021-08@2 12/21/2021, 09-2021-14@6 01/05/2021, 09-2021-16@4 12/29/2021, 09-2021-17@4 12/30/2021, 09-2021-22@3 01/04/2022 & 10-2021-27@3 02/08/2022

Distribution pattern: nationwide

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility